Envoy Medical, Inc. (COCH): R&D Expense

Annual figures by period end, from SEC filings.

$12.49M

Year ended 2025-12-31

$14.03M

Trailing 12 months to 2026-06-30

+35.9%

3-year compound annual growth

2022-12-31 R&D Expense (USD) 2025-12-31

Period ended	R&D Expense	Change YoY	Source filing
2025-12-31	$12.49M	+22.7%	2026-03-23, From 2025-01-01
2024-12-31	$10.18M	+13.7%	2026-03-23, From 2024-01-01
2023-12-31	$8.96M	+80.0%	2025-03-31, From 2023-01-01
2022-12-31	$4.97M	n/a	2024-04-01, From 2022-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
Envoy Medical, Inc. (COCH)	2025-12-31	$12.49M	+22.7%
Safe Pro Group Inc. (SPAI)	2025-12-31	$394.2K	+336.2%
Anteris Technologies Global Corp. (AVR)	2025-12-31	$69.12M	+34.3%
NutriBand Inc. (NTRB)	2026-01-31	$1.89M	-39.4%
CollPlant Biotechnologies Ltd (CLGN)	2025-12-31	$8.19M	-22.1%
ENvue Medical, Inc. (FEED)	2025-12-31	$1.76M	+93.8%
Milestone Scientific Inc. (MLSS)	2025-12-31	$449.5K	-47.7%
LogicMark, Inc. (LGMK)	2025-12-31	$617.4K	+10.5%
Jin Medical International Ltd. (ZJYL)	2025-09-30	$1.56M	+4.0%

Compare COCH, SPAI, AVR, NTRB side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗